← Leaderboards
Milan Tomic
Nanotherapeutics, Inc.
$15,158,708
Attributed
$15,158,708
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.3M · FY2019–24$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$15,158,708 · 1
By mechanism
N01$15,158,708 · 1
Top collaborators
No co-investigators on record.
Most similar at Nanotherapeutics, Inc.
Same institution · by research overlap
- Robert House$3,149,878
- James David Talton$15,179,333
- James Talton$155,864
Others in their field
Other Emerging Leaders on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Lynn Briscoe · Leidos Biomedical Research, Inc.$110,540,429
- Ted Ross · University Of Georgia$68,763,143
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$57,713,529
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Research focus
Pre-ClinicalMedical CountermeasureAdvanced DevelopmentTherapeutic CandidateResearch And DevelopmentProduct DevelopmentCommunicable DiseasesToxinBotulismNovel TherapeuticsPathway InteractionsEfficacy EvaluationSafety AssessmentSafetyBiodefenseClinical AssessmentsChemistryResearch SupportCandidate SelectionLead OptimizationEmerging Communicable DiseasesManufactureTherapeutic DevelopmentPathogen
Grant awards (6)
Advanced Development of Medical Countermeasures for Infectious Diseases$1,223,182
N01 · FY2024 · AI · contact PI
Advanced Development of Medical Countermeasures for Infectious Diseases$4,300,537
N01 · FY2023 · AI · contact PI
Advanced Development of Medical Countermeasures for Infectious Diseases$271,613
N01 · FY2022 · AI · contact PI
Advanced Development of Medical Countermeasures for Infectious Diseases$4,233,500
N01 · FY2021 · AI · contact PI
Advanced Development of Medical Countermeasures for Infectious Diseases$1,776,307
N01 · FY2020 · AI · contact PI
Advanced Development of Medical Countermeasures for Infectious Diseases$3,353,569
N01 · FY2019 · AI · contact PI